Lead Product(s) : SAN903
Therapeutic Area : Nephrology
Study Phase : Preclinical
Sponsor : University of Arhus
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : SAN903 was administrated daily during unilateral urinary obstruction the total fibrotic area was reduced by up to 43% (p>0.0001). SAN903 was well tolerated at all doses.
Product Name : SAN903
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 24, 2022
Lead Product(s) : SAN903
Therapeutic Area : Nephrology
Highest Development Status : Preclinical
Sponsor : University of Arhus
Deal Size : Inapplicable
Deal Type : Inapplicable